HK Innoen announced that its gastro‑esophageal reflux disease (GERD) treatment, K‑Cap 50 mg, has become the first oral solid dosage pharmaceutical product worldwide to obtain an Environmental Product Declaration (EPD). The company received the EPD certificate at a ceremony on 2 July in Oslo, Norway, co‑hosted by EPD‑Global and the International Sustainability Certification Institute. The EPD provides objective environmental performance data, allowing the product to demonstrate both market competitiveness and sustainability in overseas markets.
規制動向2026年9月18日•3分で読めます
HK Innoen’s GERD drug K‑Cap 50 mg earns world’s first EPD for oral solid dosage
HK Innoen’s GERD medication K‑Cap 50 mg became the first oral solid dosage drug globally to receive an Environmental Product Declaration, highlighting its sustainability credentials.
Pharmacountryチームがまとめました · 出典： KPA News
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す